510 related articles for article (PubMed ID: 24706327)
41. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
42. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.
Liao CT; Lin CY; Fan KH; Wang HM; Ng SH; Lee LY; Hsueh C; Chen IH; Huang SF; Kang CJ; Yen TC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):284-90. PubMed ID: 21075550
[TBL] [Abstract][Full Text] [Related]
43. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C
Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287
[TBL] [Abstract][Full Text] [Related]
44. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
45. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
46. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
47. Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC).
Albinger-Hegyi A; Stoeckli SJ; Schmid S; Storz M; Iotzova G; Probst-Hensch NM; Rehrauer H; Tinguely M; Moch H; Hegyi I
Int J Cancer; 2010 Jun; 126(11):2653-62. PubMed ID: 19816945
[TBL] [Abstract][Full Text] [Related]
48. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
49. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity.
Shrime MG; Bachar G; Lea J; Volling C; Ma C; Gullane PJ; Gilbert RW; Irish JC; Brown DH; Goldstein DP
Head Neck; 2009 Nov; 31(11):1482-8. PubMed ID: 19441094
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation.
Chen CH; Chuang HC; Huang CC; Fang FM; Huang HY; Tsai HT; Su LJ; Shiu LY; Leu S; Chien CY
Am J Pathol; 2013 Feb; 182(2):516-28. PubMed ID: 23219753
[TBL] [Abstract][Full Text] [Related]
51. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
52. The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma.
Choi SW; Park SY; Hong SP; Pai H; Choi JY; Kim SG
J Oral Pathol Med; 2004 Oct; 33(9):533-7. PubMed ID: 15357673
[TBL] [Abstract][Full Text] [Related]
53. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
54. Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications.
Li HX; Zheng JH; Fan HX; Li HP; Gao ZX; Chen D
J Oral Pathol Med; 2013 Aug; 42(7):547-56. PubMed ID: 23331428
[TBL] [Abstract][Full Text] [Related]
55. Analysis of p16(INK4A) expression of oral squamous cell carcinomas in Taiwan: prognostic correlation without relevance to betel quid consumption.
Chen YW; Kao SY; Yang MH
J Surg Oncol; 2012 Aug; 106(2):149-54. PubMed ID: 22354873
[TBL] [Abstract][Full Text] [Related]
56. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
57. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma.
Lee TK; Poon RT; Man K; Guan XY; Ma S; Liu XB; Myers JN; Yuen AP
Cancer Lett; 2007 Sep; 254(2):308-15. PubMed ID: 17499430
[TBL] [Abstract][Full Text] [Related]
58. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
59. Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer.
Kuk SK; Yoon HJ; Hong SD; Hong SP; Lee JI
Oral Oncol; 2016 Apr; 55():31-6. PubMed ID: 26880520
[TBL] [Abstract][Full Text] [Related]
60. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.
Shang ZJ; Liu K; Shao Z
Oral Oncol; 2009 Jun; 45(6):480-5. PubMed ID: 18752985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
